AtaiBeckley Inc. is projected to rise to $9.75 by 2027, a +36% move from its current price of $7.18. ATAI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $6.88 | $7.18 | $7.49 | -0.01% |
| Aug 2 | $6.76 | $7.18 | $7.62 | -0.01% |
| Aug 3 | $6.67 | $7.18 | $7.72 | -0.02% |
| Aug 4 | $6.60 | $7.18 | $7.81 | -0.03% |
| Aug 5 | $6.53 | $7.18 | $7.89 | -0.04% |
| Aug 6 | $6.47 | $7.18 | $7.96 | -0.04% |
| Aug 7 | $6.42 | $7.18 | $8.02 | -0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.42 | $7.18 | $8.02 | -0.05% |
| Week 2 | $6.13 | $7.17 | $8.39 | -0.10% |
| Week 3 | $5.91 | $7.17 | $8.69 | -0.15% |
| Week 4 | $5.74 | $7.17 | $8.95 | -0.20% |
| Week 5 | $5.58 | $7.16 | $9.18 | -0.25% |
| Week 6 | $5.45 | $7.16 | $9.40 | -0.30% |
| Week 7 | $5.33 | $7.15 | $9.60 | -0.36% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ATAI is the stock symbol for AtaiBeckley Inc., a healthcare company focused on mental health treatments. It operates in the United States, Germany, and Canada and participates in research, development, and commercialization activities in this area.
The company was founded in 2018 and is based in New York, New York. It was formerly known as Atai Beckley N.V. and changed its name to AtaiBeckley Inc. in December 2025. The pipeline includes BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin in Phase 2a and 2b for treatment resistant depression and alcohol use disorder; RL-007, an orally bioavailable pro-cognitive neuromodulator in Phase 2b for cognitive impairment associated with schizophrenia; ELE-101, a serotonergic psychedelic for major depressive disorder; VLS-01 in Phase 2 for TRD; EMP-01 in Phase 2 for social anxiety disorder; EGX-A & EGX-B for TRD; COMP360 for psilocybin therapy; and GRX-917 for anxiety, depression, and various neurological disorders.
It offers these programs alongside other assets within its portfolio.
ATAI is the stock ticker for AtaiBeckley Inc., a healthcare company focused on mental health therapies. The current price is $7.15 with a market capitalization of $2.63B and a market rank of 1830.
The near-term technical picture shows bullish sentiment with a 30-day range from $4.90 to $10.43. RSI14 stands at 70, while the 50-day simple moving average is $4.50 and the 200-day simple moving average is $4.31. Support sits at $3.78 and resistance at $7.15.
The multi-year forecast projects meaningful upside over time, with 2026 averaging $7.15 and a path toward higher prices in subsequent years. The forecast lists years through 2050 with rising averages and substantial potential ROIs, culminating in strong long-run upside.
A major floor 58.5% below — a decisive break under it would weaken the trend.
The nearest floor, 43.6% below — buyers have tended to step in here.
Price is pressing into resistance (0.6% away) — a breakout level to watch.
A major ceiling 29.8% above — clearing it would confirm fresh momentum.
Key ATAI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ATAI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.18 | Buy | $7.16 | Buy |
| MA 10 | $7.18 | Buy | $6.96 | Buy |
| MA 20 | $6.30 | Buy | $6.43 | Buy |
| MA 50 | $5.12 | Buy | $5.50 | Buy |
| MA 100 | $4.53 | Buy | $4.90 | Buy |
| MA 200 | $4.40 | Buy | $4.40 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 73.71 | Sell |
| Stoch RSI (14) | 92.03 | Sell |
| CCI (20) | 60.89 | Neutral |
| Williams %R (14) | -1.78 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 26.63 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 98.22 | Sell |
| TRIX (15) | 1.86 | Buy |
| Awesome (5,34) | 1.66 | Buy |
| Ultimate (7,14,28) | 77.61 | Sell |
| Momentum (10) | 0.03 | Buy |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 7.18 | Sell |
| ADX (14) | 36.06 | Buy |
| ATR (14) | 0.17 | Info |
Sentiment is bullish from the near term perspective, with RSI14 at 70 indicating strong momentum.
Key moving averages frame near-term dynamics: SMA50 is $4.50 and SMA200 is $4.31, reinforcing a positive bias as price action trades above prior support levels. A clear resistance level is cited at $7.15, with a support level at $3.78.
The 30-day range spans from $4.90 to $10.43, highlighting notable volatility within the month. Annualized volatility is listed at 100%, underscoring the sensitivity to market moves in the short run.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.35 | $7.18 | $9.43 | 0% | Neutral | |
| $7.40 | $9.75 | $13.81 | +36% | Bullish | |
| $7.21 | $9.95 | $14.87 | +39% | Bullish | |
| $7.43 | $10.67 | $16.60 | +49% | Bullish | |
| $9.06 | $13.46 | $21.68 | +87% | Bullish | |
| $11.10 | $17.03 | $28.26 | +137% | Bullish | |
| $14.28 | $22.57 | $38.45 | +214% | Bullish | |
| $15.22 | $24.76 | $43.18 | +245% | Bullish | |
| $15.02 | $25.13 | $44.77 | +250% | Bullish | |
| $16.42 | $28.20 | $51.26 | +293% | Bullish | |
| $26.77 | $52.10 | $102.83 | +626% | Bullish | |
| $53.87 | $119.70 | $265.63 | +15.7x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.35 | $7.18 | $8.39 | +0.00% |
| August 2026 | $5.87 | $6.97 | $8.52 | -2.97% |
| September 2026 | $5.93 | $7.13 | $8.90 | +2.38% |
| October 2026 | $6.04 | $7.35 | $9.31 | +2.99% |
| November 2026 | $5.88 | $7.20 | $9.25 | -1.92% |
| December 2026 | $5.87 | $7.26 | $9.43 | +0.77% |
Click any year to see its month-by-month ATAI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ATAI price prediction for 2026 points to an average of $7.18 (low $3.35, high $9.43) — a potential gain of 0% on today's $7.18. Price action looks broadly range-bound.
In 2027, ATAI is projected to trade between $7.40 and $13.81, averaging $9.75 — a potential gain of +36% from today's $7.18. That is up +36% on the projected 2026 average. Buyers look set to stay in control over this stretch.
AtaiBeckley Inc.'s 2028 outlook centres on $9.95, within a $7.21 to $14.87 range. That is up +2% on the projected 2027 average. That marks a +39% change versus current levels. Momentum favours further upside here.
By 2029, ATAI could reach as high as $16.60, with a base case around $10.67 and support toward $7.43 — roughly +49% from $7.18. Buyers look set to stay in control over this stretch.
Expect ATAI to range from $9.06 to $21.68 through 2030. The $13.46 average target implies a +87% move from current prices. That is up +26% on the projected 2029 average. Momentum favours further upside here.
The ATAI price prediction for 2031 points to an average of $17.03 (low $11.10, high $28.26) — a potential gain of +137% on today's $7.18. Buyers look set to stay in control over this stretch.
In 2032, ATAI is projected to trade between $14.28 and $38.45, averaging $22.57 — a potential gain of +214% from today's $7.18. That is up +33% on the projected 2031 average. Momentum favours further upside here.
AtaiBeckley Inc.'s 2033 outlook centres on $24.76, within a $15.22 to $43.18 range. That is up +10% on the projected 2032 average. That marks a +245% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, ATAI could reach as high as $44.77, with a base case around $25.13 and support toward $15.02 — roughly +250% from $7.18. Momentum favours further upside here.
Expect ATAI to range from $16.42 to $51.26 through 2035. The $28.20 average target implies a +293% move from current prices. That is up +12% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The ATAI price prediction for 2040 points to an average of $52.10 (low $26.77, high $102.83) — a potential gain of +626% on today's $7.18. Momentum favours further upside here.
In 2050, ATAI is projected to trade between $53.87 and $265.63, averaging $119.70 — a potential gain of +15.7x from today's $7.18. That is up +130% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ATAI today (≈ 139.275766 ATAI) could be worth
$16,671.51
+$15,671.51 (+1567%) by 2050 · US Dollar
Based on the average projected ATAI price of $119.7 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ATAIwould be worth at today's price.
$1,000 invested in ATAI on Jul 30, 2025 (≈ 288.184436 ATAI) would be worth
$2,069.16
+$1,069.16 (+106.9%) today · 2.07× · US Dollar
Based on a ATAI entry price of $3.47 vs. today's $7.18.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.17 | $1,001.39 | +0.1% |
| 1 month ago | $5.27 | $1,362.43 | +36.2% |
| 3 months ago | $4.14 | $1,734.3 | +73.4% |
| 6 months ago | $3.76 | $1,909.57 | +91.0% |
| 1 year ago | $3.47 | $2,069.16 | +106.9% |
| All time (5.0y) ago | $15.64 | $459.08 | -54.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ATAI forecast.
Our base-case forecast reaches $14.00 around 2031.
Implied market cap at $14.00: $5.18B
The multi-year forecast shows a bullish trajectory across the period, with 2026 having a neutral stance and an average price of $7.15, implying flat near-term performance. By 2027 the average is $9.74 with a 36.3% ROI and a bullish sentiment, and it rises further in 2028 to an average of $9.03 with a 26.3% ROI.
In 2029 the average price is $9.71 with a 35.8% ROI and a bullish outlook. By 2030 the forecast envisions an average of $12.69 with a 77.5% ROI and a bullish sentiment. The trajectory extends to 2040, with an average of $47.45 and a 563.6% ROI, and a 2050 average of $118.52 with a 1557.7% ROI, both rated bullish.
Overall, the forecast portrays rising values across decades, suggesting substantial long-run upside while acknowledging the inherent uncertainty and that these are estimates, not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $12.69 with a min of $7.85 and a max of $22.02, and an estimated ROI of 77.5% with a bullish sentiment.
The forecast shows rising averages from 2027 onward with bullish sentiment in 2027 ($9.74 avg) and beyond, including strong long-run upside (2040 avg $47.45, ROI 563.6%; 2050 avg $118.52, ROI 1557.7%). Note that 2026 is neutral with an avg of $7.15 and ROI of 0%.
Yes. The 2040 forecast lists a maximum of $104.13, and the 2050 forecast lists a maximum of $272.60, indicating the potential to surpass $100 at some point in the future.
For 2026, the min is $3.35, the average is $7.15, and the max is $9.77, with a 0% ROI and a neutral sentiment.
The near-term setup is bullish with RSI 14 at 70. The 50-day moving average is $4.50 and the 200-day moving average is $4.31, with support at $3.78 and resistance at $7.15. The 30-day range is $4.90 to $10.43 and volatility is listed at 100%.
AtaiBeckley Inc. Community Discussion
0Share your AtaiBeckley Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.